Here are some questions to get your weekend reading started. Can Yelp predict hospital mortality? Can AI solve a radiologist shortage in the UK? How do we get the LA/Long Beach port back up and running? Why is CMS in Baltimore rather than DC? What to do when you’re down to your last diaper?
A taste of their own medicine? Impact of COVID-19 on mental health. COVID-19 vaccines work for veterans. No mandate but make the unvaccinated pay their own way? Patient-focused drug development.
Favorite paper. Covered California’s out-of-pocket drug max Google moves to first price auction. FDA on RWD for regulatory decision-making. NBA and health care fraud.
Value of nurse practitioners for inpatient care. DTx and outcomes-based contracting. Is there a limit on human survival? Back to normal in Madrid? (en español) “Not statistically significant” is not the same as zero and “When Should Clinicians Act on Non–Statistically Significant Results From Clinical Trials?”
Did COVID-19 affect quality of life valuations? Medication adherence measurement: claims vs. pharmacy fill data. “Patients’ free choice of physicians is not always good” Digital Health funding stats. Academic research on digital health. Impact of hospice care on family costs. Impact of VBID for patients with diabetes. “Being sick is a full-time job”
Federal government worker vaccine mandate. Hospitals vs. nurses on vaccine mandates. AMA response to Medicare physician fee schedule revisions. Boston, SF, San Diego. The end of nursing homes in Canada?
Biden drug price reform plan. PhRMA response. Vax or tax mandate: CEO response. Cost differences for infused drugs. COVID-19: Should you attend a football game? The beer police.
Can you make a telehealth visit from Virginia to a Maryland physician? Florida vaccination rates rising. Ida hits New York. State-by-state school spending and education outcomes California vaccine mandate for health workers
Co-pays for COVID hospitalizations. Impact of price negotiations on Part D premiums. Accelerated Approval and Value-Based Pricing? Halo Health CEO interview. Living in LA.
The principal force behind declining happiness has been… The problem of tinkering with the safety net. Market power vs. adverse selection. New COVID detector. Has Baumol’s cost disease been cured?
How consultants help hospitals with bundled payments. 76% of small businesses worried Delta variant will impede economic recovery. Scott Alexander on the FDA. Being a nurse is hard. NHS waiting times may not return to normal until 2025.
Real-world cost of health interventions. Looks and career success. Improved PubMed search. A-APM vs. MIPS Political alignment and tax evasion.
$2.2 trillion deficit in 2021. Adverse selection and ACA plans. COVID-19 and panic drug purchasing. Amazon: $6 six-month prescriptions Pharmacist’s opinion on value-based comprehensive medication management
Administrative simplicity vs. single payer. 340B case heads to the Supreme Court. Marketing and mammograms NY ends state of emergency: what happens to out-of-state licensed health care professionals? Key facts on the Delta Variant.
Evaluating the robustness of CMS Hospital VBP measurement system. ICER’s gene therapy evaluations. Who are high-frequency hospital users? EHR and malpractice. What is Evio? Has in vivo gene editing come of age?
Why the FDA approved aducanumab. How to report changes in clinical trial protocols due to COVID-19 (CONSERVE) Democrats eye Medicare and Medicaid expansions. ACA and biosimilars. The challenges of improving quality of care. Native Americans and health equity.
Supreme court upholds ACA. Nature on lab-leak hypothesis. The geography of global warming. The return of boarding houses. Business perspective on single payer.
Physician compensation during the pandemic. Caring for an aging nation. The debt snowball. Infection rate among the unvaccinated is as high as it was back in January CMS all-in on mandatory pay-for-performance reimbursement. Patients minimize cost by reducing Q, not trying to minimize P.
Affordability vs. Innovation. “standardizing contracts generates larger savings with less variance than savings from single‐payer strategies” The placebo effect examined Income growth in knowledge industries. Alcohol sales restrictions and alcohol poisoning mortality.
LGBTQ Economics. Does health insurance improve health outcomes for cancer patients? Shattered. Mr. Jim. KHN: “Moderna…announced in October that it would not enforce its covid-related patents during the pandemic. Even so, no known independent producer has used the available patents to replicate the company’s mRNA vaccine. Experts say that’s telling.”
Disability and distress. COVID-19 vaccine showdown: California vs. Texas. Opioid trajectories. “beliefs…are insufficiently skeptical about nondisclosed information in the absence of repeated feedback” What is ARPA-H?
ACA ‘family glitch’ Hospital price transparency. NBA players and COVID-19. Good work if you can get it. SPACs and digital health. Dark chocolate is not a superfood.
Urgent care vs. ED. FDA review of old drugs. R&D incentives and innovation spillovers. Pharmaceuticals and the Developing World. Care managers vs cost centers.
Misperceptions of people with disabilities. A bundled payment success story. Do people with COVID-19 tell their employers? The history of vaccine backlash. Oral COVID-19 vaccine? Things are getting better. Vaccines in Gibraltar.
Public health spending lags medical spending. On the importance of pre-analysis protocols. Medicare spends over $10 billion on COVID-19 in 2020. Home health = infrastructure? Will enrollment in cancer clinical trials continue to be difficult post-COVID? Yes vs No.
Health insurance coverage for sexual minorities. PhD = doctor? Ghost rides. Mini-COBRA. Pasaporte corona en Dinamarca.
COVID-19 vaccine monitor. Impact of immunotherapies on Medicare cancer cost. Amazon Care telehealth. What’s wrong with my model? Is Brazil’s health system collapsing?
ISPOR’s new Science Strategy. MedPAC: “CMMI has put 54…[alternative payment] models into practice during the past decade. But only four of them have met the criteria for expansion.” Lifestyle and mental health disruptions since COVID-19. Impact of COVID-19 on small business CDC guidance for the fully vaccinated
Food insecurity and health care spending. Access in a new world. Credibility Revolutionistas. Do individuals with limited English proficiency use telehealth? Desk clearing and drug safety. UCI: Re-open California schools
Impact of reducing air pollution on health expenditures. Does psychotherapy work? Does losing health insurance increase claims for SSI? Why governments decide to de-fund medical services. Can nonrandomized RWE replicate RCTs?
Medicare Advantage star ratings and quality. ACA and cancer detection. We can open schools safely. SF eliminates gas stoves? Overshooting the output gap?
Cost of care for residential opioid use disorder treatment 2021 Deficit: $2.3 trillion GAO recommendations on the COVID-19 supply chain “recreational marijuana policies were positively associated with opioid‐related hospitalizations” COVID and mental health. A tale of two thresholds. Hedonic vs. capability views on health. Patients at the center of value assessment.
Appropriateness of step therapy. Fiscal impact of anti-obesity medications. Can individual hospitals survive? A health economist takes on Kenya’s pandemic. The invisible graveyard.
Faster drug access in the Netherlands (Drug Access Protocol) “Hospitals might annually exploit extra reimbursements of about 8%–10% from primary diagnosis manipulations” Comparison of costs and benefits of European country COVID-19 responses Health Affairs’ priorities for Biden. Fauci on Trump.
Pharmacy desserts. Why Israel leads in COVID vaccinations (speculative). Does temperature screening really work? A mRNA vaccine for multiple sclerosis? Mark Cuban Cost Plus Drugs.
Palau: A leader in health? The Great Bucatini Shortage of 2020. Bayesian fatigue. Illinois to cover undocumented seniors. Excess returns in Rx supply chain?
No more snow days in medicine. Hospitals overwhelmed. Drug lag. Racial bias and treatment algorithms. Number of COVID-19+ individuals that will show up at your event.
Am I disabled? EHR burden on physicians: US vs. rest of world. COVID-19 vs. religion. Toilet politics. Giannis on COVID-19. Bonus: Largest US metro areas across decades (for some reason I find this fascinating)
Who gets the vaccine first? Amazon Pharmacy. What’s different now? Interoperability and the pandemic. Becoming homebound.
US debt rises about 100% of GDP. Racism and sickle cell disease. Health insurance among the self-employed. The interaction of minimum drinking age laws and genetics on binge drinking. Sanctuary policies and crime. Does social care prevent healthcare utilization? HDHPs impact the extensive but not intensive margins. DITF .Impact of SES on knee pain.
Performance of private equity-owned nursing homes during COVID-19 GrimAge #WhiteCoatsForBlackLives Jews and Catholics come together in Wisconsin. The disappearance of the primary care physical examination. Remdesivir final report. (Self-reported) mask use tops 90%.
Clinical trials going digital. JAMA return-to-play guidance. Would a COVID-19 vaccine produce larger health or economic benefits? Pros and cons of telemedicine. Are we there yet? A review of 4 value-based care programs.
AZ/J&J resume COVID-19 trials. Nature and Predictors of Response Changes in Modified-Delphi Panels. Thanksgiving and COVID-19 risks. Misleading maps? Average annual premium for a family of four is $21,342.
Long waits for COVID-19 tests. Quantifying the benefits of the Clean Air Act. Pooled testing. Double dipping? Excess deaths trends.
Why payers support prior authorizations. Russia health care fact of the day. Doug Glanville, comma. “Schizophrenia is not a casserole illness.” Mortality vs. new cases.
Modelling COVID-19 dynamics. The cost of medication non-adherence. Hydroxychloroquine is out; dexamethasone is in. CMS and value-based pricing. PhRMA: After 6 months of the COVID-19 pandemic, where are we now?